Post-earnings recap
Reported
Tue, May 10, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported a loss of $0.12 per share, which was worse than expected, contributing to a 4.6% decline in stock price. The lack of revenue figures and guidance may have added to investor uncertainty. Overall, the results suggest challenges ahead for the company.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.12 | N/A | -29.03% |
| Revenue | — | N/A | — |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.